DEEP Project

The project aims to make deferiprone (the first oral iron chelator developed in Europe) available as first-line treatment in children of any age, affected by β-thalassaemia major and other transfusion dependent haemoglobinopathies, the more frequent anaemia in the world (especially in the Mediterranean). The Project will integrate the results of 3 PK/efficacy and safety studies in the existing inf  ...